Skip to content

The Impact of Bifidobacterium and Its Metabolites on Postoperative Complications of Pancreatic Surgery

The Impact of Bifidobacterium and Its Metabolites on Postoperative Complications of Pancreatic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500109645
Enrollment
Unknown
Registered
2025-09-23
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic disease

Interventions

Intervention group:Oral intake of probiotics
Control group:Normal clinical treatment

Sponsors

The First Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing pancreatic surgery for space-occupying lesions at the First Affiliated Hospital of Harbin Medical University; 2.No antibiotic treatment within two weeks preoperatively, absence of severe diarrhea (=3 bowel movements/day), and stable dietary patterns.

Exclusion criteria

Exclusion criteria: 1.Patients aged >80 years with multiple comorbidities deemed ineligible for surgery; 2.Cases lost to follow-up; 3.Individuals unable to provide fecal samples during the perioperative period

Design outcomes

Primary

MeasureTime frame
pancreatic fistula ;Endocrine and exocrine dysfunction;Bile fistula;

Secondary

MeasureTime frame
Ascitic fluid amylase;Immune-related indicators;

Countries

China

Contacts

Public ContactSun Bei

The First Affiliated Hospital of Harbin Medical University

sunbei70@163.com+86 136 0365 6935

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026